Emerging Biomarkers for Early Detection of Neurodegenerative Diseases: A Comprehensive Review

Abstract

Neurodegenerative diseases pose a significant challenge to healthcare systems worldwide due to their progressive nature and lack of effective treatments. Early detection of these diseases is crucial for timely intervention and management. This paper explores the landscape of emerging biomarkers for the early detection of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS). By examining recent research findings, this review discusses promising biomarkers from various sources such as cerebrospinal fluid, blood, neuroimaging, and genetic markers. Understanding these biomarkers' potential could revolutionize early diagnosis, enhance patient care, and facilitate the development of targeted therapies.

Keywords: Biomarkers, Neurodegenerative Diseases, Early Detection, Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Amyotrophic Lateral Sclerosis.